Restore Vision and Forge Biologics Partner to Advance RV-001 Gene Therapy for Retinitis Pigmentosa Through Clinical Development Restore Vision, Inc., a clinical-stage biotechnology company focused on developing innovative gene therapies…
Ashlins Pharmaceuticals Signs Exclusive Global Licensing Agreement with Lee’s Pharmaceutical Holdings to Advance Interferon Alpha-2b Drug Development Ashlins Pharmaceuticals has announced that its wholly owned subsidiary, Ashlins Ocular Pharmaceuticals, Inc.,…
Brenus Pharma Secures €11 Million Series A Extension to Advance Lead Cancer Immunotherapy and Expand Proprietary In Vivo Immunotherapy Platform Brenus Pharma has announced the successful completion of an €11…
LAPIX Therapeutics Completes Enrollment in Rheumatoid Arthritis Cohort of LPX-TI641 Clinical Trial, Advancing Development of First-in-Class Oral TIM 3/4 Agonist LAPIX Therapeutics, a clinical-stage biotechnology company focused on developing innovative…
Flashpoint Therapeutics Celebrates Founder Professor Chad A. Mirkin’s Selection for the 2027 ACS Priestley Medal Flashpoint Therapeutics, a biotechnology company focused on advancing next-generation nanomedicines, has announced that its founder,…
DivcoWest Announces Collegium Pharmaceutical as One Lincoln Tenant DivcoWest, a DivCore Capital company and a leading national commercial real estate investment firm, has announced that Collegium Pharmaceutical, a biopharmaceutical company…
Kinaset Therapeutics Doses First Patient in Phase 2b Trial of Frevecitinib for Severe Asthma Kinaset Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative inhaled therapies for serious respiratory diseases,…
Immunomic Therapeutics Doses First Patient in Phase 1 Trial of ITI-5000 Therapeutic Cancer Vaccine for Triple-Negative Breast Cancer Immunomic Therapeutics, Inc. (ITI), a clinical-stage biotechnology company and U.S.-based subsidiary of…
Clinigen Appoints Greg Skalicky as Group CEO to Lead Next Phase of Global Growth and Patient Access Strategy Clinigen, a global pharmaceutical services company dedicated to improving patient access to…
Bayer and Henry Ford Health Form Strategic Partnership to Expand Patient Access to Clinical Trials and Accelerate Medical Innovation Bayer, a global life sciences company with a broad portfolio spanning…
iVeena Delivery Systems Completes Phase 1 Trial of IVMED-85, Advancing Novel Eye Drop Therapy for Pediatric Myopia iVeena Delivery Systems, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing innovative…
Aptar Pharma Introduces Collaborative System-Level Framework to Advance Injectable Drug Delivery Development Aptar Pharma, a global leader in drug delivery, dosing, protection technologies, and pharmaceutical services, has announced the launch…